Figure E2: Proposed algorithm for serological diagnosis of IgE mediated cannabis sativa allergy. Performance of component resolved diagnosis based on availability.
REFERENCES
1. Tessmer A, Berlin N, Sussman G, et al. Hypersensitivity reactions to marijuana. Ann Allergy Asthma Immunol 2012;108(4):282-4. doi: 10.1016/j.anai.2012.01.008 [published Online First: 2012/04/04]
2. Nayak AP, Green BJ, Sussman G, et al. Characterization of Cannabis sativa allergens. Ann Allergy Asthma Immunol 2013;111(1):32-7. doi: 10.1016/j.anai.2013.04.018 [published Online First: 2013/06/29]
3. Decuyper, II, Van Gasse AL, Faber MA, et al. Exploring the Diagnosis and Profile of Cannabis Allergy. J Allergy Clin Immunol Pract2019;7(3):983-89 e5. doi: 10.1016/j.jaip.2018.09.017 [published Online First: 2018/10/03]
4. Ebo DG, Decuyper, II, Rihs HP, et al. IgE-binding and mast cell activating capacity of the homologue of the major birch pollen allergen and profilin from Cannabis sativa. J Allergy Clin Immunol Pract2021 doi: 10.1016/j.jaip.2021.02.012 [published Online First: 2021/02/20]
Ine I. Decuyper, MD, PhD1,2, Hans-Peter Rihs, PhD3, Christel H. Mertens, MLT1, Athina Ludovica Van Gasse, MD, PhD1,2, J. Elst, MSc1, Margaretha A. Faber, MD, PhD1, Margo M. Hagendorens, MD, PhD1,2, Vito Sabato, MD, PhD1,4, and Didier G. Ebo, MD, PhD1,4